Meeting Coverage:

American Glaucoma Society

AGS: 2020

LiGHT: Efficacy and Cost Effectiveness

Show Description +

Sarwat Salim, MD, FACS, sits down with Gus Gazzard, MD, FRCOphth, to discuss the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. Dr. Gazzard details the study design, efficacy data, and cost effectiveness of selective laser trabeculoplasty versus medication.

Posted: 1/28/2020

Up Next


Glaucoma and the Ocular Surface

Laura A. Voicu, MD, Sarwat Salim, MD

MIGS in the Highly Hyperopic Patient

Leonard K. Seibold, MD,

OHTS: 20-Year Follow-Up

Eve Higginbotham, MD

Founding a Glaucoma Society

M. Bruce Shields, MD, Sarwat Salim, MD

Classification and Staging of Glaucoma

M. Bruce Shields, MD, Sarwat Salim, MD

MIGS in Kids

James D. Brandt, MD, Sarwat Salim, MD

Corneal Hysteresis and Glaucoma Surgery

Davinder S. Grover, MD, MPH

Autonomous AI's Potential in Glaucoma

Michael D. Abramoff, MD, PhD

MIGS in the Highly Myopic Patient

Constance Okeke, MD, MSCE

LiGHT: Efficacy and Cost Effectiveness

Sarwat Salim, MD, FACS, sits down with Gus Gazzard, MD, FRCOphth, to discuss the Laser in Glaucoma and Ocular Hypertension (LiGHT) trial. Dr. Gazzard details the study design, efficacy data, and cost effectiveness of selective laser trabeculoplasty versus medication.

Posted: 1/28/2020


Please log in to leave a comment.

More From AGS: 2020 Coverage

OHTS: 20-Year Follow-Up

Eve Higginbotham, MD

Founding a Glaucoma Society

M. Bruce Shields, MD, Sarwat Salim, MD

Classification and Staging of Glaucoma

M. Bruce Shields, MD, Sarwat Salim, MD